Advocacy intelligence hub — real-time data for patient organizations
H.P. Acthar Gel: FDA approved
To treat infantile spasms
VIGABATRIN: FDA approved
For infantile spasms (IS) - 1 month to 2 years of age.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
H.P. Acthar Gel
Questcor Pharmaceuticals, Inc.
Patient Assistance Programs1
VIGABATRIN
Hikma Pharmaceuticals USA Inc
VIGABATRIN
(VIGABATRIN)Hikma Pharmaceuticals USA Inc
Anti-epileptic Agent [EPC]
12.1 Mechanism of Action The precise mechanism of vigabatrin’s anti-seizure effect is unknown, but it is believed to be the result of its action as an...
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
FDA Approves VIGABATRIN
VIGABATRIN (VIGABATRIN) received FDA approval.
View all Cryptogenic late-onset epileptic spasms specialists →